N/A
N=168
Initiating Contraception After Emergency Contraception From Pharmacy
Contraceptive Use After Emergency Contraception
Bottom Line
View on ClinicalTrials.gov: NCT01738971 ↗Enrolled (actual)
168
Serious AEs
0.0%
Results posted
Aug 2014
Primary outcome: Primary: Self-reported Uptake of Effective Ongoing Contraception (Not Condoms) — 5; 13; 22; 0 participants — p=<0.001
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- rapid access (Other); one month progestogen only pill (Other)
- Age
- Pediatric, Adult · 16+ yrs
- Sex
- Female
- Sponsor
- University of Edinburgh
- Primary completion
- Dec 2012
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Self-reported Uptake of Effective Ongoing Contraception (Not Condoms) |
5; 13; 22; 0; 5; 3 | <0.001 sig |
| SECONDARY Pharmacy Recruitment Rates |
54; 58; 56; 6; 2; 4 | — |
| SECONDARY Completeness (Quality) of Data Recorded by Pharmacists (Numbers of Women Attending for EC,Demographics of All Attendees- Age, Ethnicity Etc) |
— | — |
| SECONDARY Proportion of Women Who Agree to Participate Who Can be Successfully Contacted |
35; 28; 39; 19; 30; 17 | — |
Summary
Pharmacists do not provide immediate contraception to women after emergency contraception (EC); they can only give advice on local contraceptive services.
The investigators wish to establish the following 2 pharmacy- based interventions in NHS Lothian, designed to increase uptake of effective contraception as soon as possible, after EC
1. Pharmacists would provide one packet of progestogen-only pills, giving women one month to arrange an appointment with contraceptive services.
2. Rapid access to a family planning clinic upon presentation of the empty EC packet. Women would be seen as a 'walk-in' and contraception provided.
If feasible, these interventions could reduce unintended pregnancies.
Participating pharmacies will be randomised to provide one of the interventions, or standard care (verbal/written advice on local contraceptive services).
Women requesting EC from study pharmacies will be recruited by the research nurse/doctor to participate in the study that will involve them consenting to contact by telephone 6-8 weeks after EC by the researcher, to evaluate the interventions in terms of :
(i) determine women's experiences/ views of the interventions and control. (ii) determine if women have commenced effective contraception and if not , reasons why.
A subset of 12 women will also be invited for in-depth interview to collect more detailed qualitative data on their EC experience.
The investigators also wish to (iii) explore pharmacists views on the interventions
Data from this pilot will enable the investigators to determine whether a larger multisite study is feasible. The aims of a larger study being to determine if either of the two interventions being tested result in an increased proportion of women using effective ongoing contraception compared to the control.
Eligibility Criteria
Inclusion Criteria
- age >= 16 yrs
- requesting emergency contraception
- eligible for emergency contraception
- written , informed consent
Exclusion Criteria
- age < 16 yrs
- not able to give written , informed consent
Data sourced from ClinicalTrials.gov (NCT01738971). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.